Prognostication and risk-adapted therapy of hodgkins lymphoma using positron emission tomography

Yvette L. Kasamon

doi:10.1155/2011/271595

Prognostication and risk-adapted therapy of hodgkins lymphoma using positron emission tomography

Yvette L. Kasamon

School of Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The use of ¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in the risk stratification of Hodgkins lymphoma through midtreatment PET is reviewed, with a focus on management implications in newly diagnosed and relapsed disease. How to tailor treatment on the basis of the interim PET result is not yet defined but is the subject of ongoing trials.

Original language	English (US)
Article number	271595
Journal	Advances in Hematology
Volume	2011
DOIs	https://doi.org/10.1155/2011/271595
State	Published - 2011

ASJC Scopus subject areas

Hematology

Access to Document

10.1155/2011/271595

Cite this

@article{5756bb57082a4fb698dc09c6d7b8a7ee,

title = "Prognostication and risk-adapted therapy of hodgkins lymphoma using positron emission tomography",

abstract = "The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in the risk stratification of Hodgkins lymphoma through midtreatment PET is reviewed, with a focus on management implications in newly diagnosed and relapsed disease. How to tailor treatment on the basis of the interim PET result is not yet defined but is the subject of ongoing trials.",

author = "Kasamon, {Yvette L.}",

year = "2011",

doi = "10.1155/2011/271595",

language = "English (US)",

volume = "2011",

journal = "Advances in Hematology",

issn = "1687-9104",

publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Prognostication and risk-adapted therapy of hodgkins lymphoma using positron emission tomography

AU - Kasamon, Yvette L.

PY - 2011

Y1 - 2011

N2 - The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in the risk stratification of Hodgkins lymphoma through midtreatment PET is reviewed, with a focus on management implications in newly diagnosed and relapsed disease. How to tailor treatment on the basis of the interim PET result is not yet defined but is the subject of ongoing trials.

AB - The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for response assessment in lymphoma is now widespread. Prognostic information obtained from PET performed after two to three cycles of chemotherapy may guide more individualized, risk-adapted therapeutic strategies. Progress in the risk stratification of Hodgkins lymphoma through midtreatment PET is reviewed, with a focus on management implications in newly diagnosed and relapsed disease. How to tailor treatment on the basis of the interim PET result is not yet defined but is the subject of ongoing trials.

UR - http://www.scopus.com/inward/record.url?scp=79952227157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952227157&partnerID=8YFLogxK

U2 - 10.1155/2011/271595

DO - 10.1155/2011/271595

M3 - Article

C2 - 21253532

AN - SCOPUS:79952227157

SN - 1687-9104

VL - 2011

JO - Advances in Hematology

JF - Advances in Hematology

M1 - 271595

ER -

Prognostication and risk-adapted therapy of hodgkins lymphoma using positron emission tomography

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this